Simplex Trading
XBIT icon

Simplex Trading’s XBiotech XBIT Stock Holding History

Simplex Trading’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-67
Closed -$162 – 10335
2025
Q4 		$160 Sell
67
-255
-79% -$629 ﹤0.01% 8268
2025
Q3 		$0 Sell
322
-542
-63% -$1.6K ﹤0.01% 10223
2025
Q2 		$2K Buy
+864
New +$2.51K ﹤0.01% 8231
2024
Q4 		– Sell
-159
Closed -$1.08K – 9781
2024
Q3 		$1K Buy
159
+35
+28% +$230 ﹤0.01% 8307
2024
Q2 		$0 Sell
124
-104
-46% -$802 ﹤0.01% 9977
2024
Q1 		$1K Sell
228
-398
-64% -$2.28K ﹤0.01% 8670
2023
Q4 		$2K Buy
626
+462
+282% +$1.84K ﹤0.01% 8375
2023
Q3 		$0 Sell
164
-309
-65% -$1.55K ﹤0.01% 9997
2023
Q2 		$2K Buy
473
+388
+456% +$1.75K ﹤0.01% 8508
2023
Q1 		$0 Buy
+85
New +$317 ﹤0.01% 10284
2022
Q3 		– Sell
-146
Closed -$687 – 11020
2022
Q2 		$0 Buy
146
+100
+217% +$673 ﹤0.01% 11261
2022
Q1 		$0 Sell
46
-100
-68% -$1K ﹤0.01% 11529
2021
Q4 		$1K Sell
146
-9,129
-98% -$119K ﹤0.01% 10268
2021
Q3 		$153K Buy
9,275
+200
+2% +$3.19K ﹤0.01% 6015
2021
Q2 		$150K Buy
9,075
+7,069
+352% +$120K ﹤0.01% 6134
2021
Q1 		$34K Buy
+2,006
New +$37.5K ﹤0.01% 7023
2020
Q3 		– Sell
-3,305
Closed -$57K – 8648
2020
Q2 		$45K Sell
3,305
-9,962
-75% -$140K ﹤0.01% 5592
2020
Q1 		$140K Buy
13,267
+8,776
+195% +$143K ﹤0.01% 4007
2019
Q4 		$83K Buy
4,491
+4,253
+1,787% +$54.8K ﹤0.01% 4703
2019
Q3 		$2K Buy
+238
New +$1.94K ﹤0.01% 6968
2019
Q2 		– Sell
-1,167
Closed -$12K – 7896
2019
Q1 		$12K Buy
+1,167
New +$9.46K ﹤0.01% 6065
2018
Q4 		– Sell
-4,082
Closed -$16.7K – 7935
2018
Q3 		$12K Buy
4,082
+2,848
+231% +$11.1K ﹤0.01% 6329
2018
Q2 		$5K Sell
1,234
-5,076
-80% -$22.9K ﹤0.01% 6738
2018
Q1 		$33K Buy
+6,310
New +$29.1K ﹤0.01% 2857
2017
Q3 		– Sell
-5,085
Closed -$24K – 6765
2017
Q2 		$23K Sell
5,085
-12,856
-72% -$123K ﹤0.01% 3178
2017
Q1 		$295K Buy
+17,941
New +$235K 0.01% 981
2016
Q4 		– Sell
-4,086
Closed -$54.4K – 6637
2016
Q3 		$54K Buy
+4,086
New +$59.9K ﹤0.01% 2039

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's XBIT Position: Q1 2026 in Review

Simplex Trading sold out of XBiotech (XBIT) in Q1 2026, closing a stake of 67 shares — an estimated $162 sold.

Simplex Trading first reported a position in XBIT in Q3 2016 and held it in 27 quarters. The position peaked at $295K in Q1 2017. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Simplex Trading reported no remaining XBiotech position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 67 XBiotech shares in Q1 2026, an estimated $162.
  • Simplex Trading first reported a position in XBiotech in Q3 2016 and held it in 27 quarters.
  • Simplex Trading's XBiotech position peaked at $295K in Q1 2017.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.